PMDA — authorised 18 June 2019
- Marketing authorisation holder: DAIICHI SANKYO COMPANY, LIMITED
- Status: approved
🇯🇵 Vanflyta in Japan
PMDA authorised Vanflyta on 18 June 2019
Marketing authorisation
Vanflyta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Vanflyta approved in Japan?
Yes. PMDA authorised it on 18 June 2019.
Who is the marketing authorisation holder for Vanflyta in Japan?
DAIICHI SANKYO COMPANY, LIMITED holds the Japanese marketing authorisation.